Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

T cell Bispecific Antibodies in Node-Positive Breast Cancer: Novel Therapeutic Avenue for MHC class I Loss Variants.

Messaoudene M, Mourikis TP, Michels J, Fu Y, Bonvalet M, Lacroix-Trikki M, Routy B, Fluckiger A, Rusakiewicz S, Roberti MP, Cotteret S, Flament C, Poirier-Colame V, Jacquelot N, Ghiringhelli F, Caignard A, Eggermont AMM, Kroemer G, Marabelle A, Arnedos M, Vicier C, Dogan S, Jaulin F, Sammut SJ, Cope W, Caldas C, Delaloge S, McGranahan N, André F, Zitvogel L.

Ann Oncol. 2019 Mar 29. pii: mdz112. doi: 10.1093/annonc/mdz112. [Epub ahead of print]

PMID:
30924846
2.

Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.

Sakr R, Renneville A, Saada V, Cotteret S, Martin JE, Droin N, Selimoglu-Buet D, Besse B, Hollebecque A, Marzac C, Pasquier F, Micol JB, De Botton S, Mir O, Solary E, Willekens C.

Leuk Lymphoma. 2018 Jul;59(7):1742-1745. doi: 10.1080/10428194.2017.1397669. Epub 2017 Nov 8. No abstract available.

PMID:
29115897
3.

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.

Semeraro M, Rusakiewicz S, Minard-Colin V, Delahaye NF, Enot D, Vély F, Marabelle A, Papoular B, Piperoglou C, Ponzoni M, Perri P, Tchirkov A, Matta J, Lapierre V, Shekarian T, Valsesia-Wittmann S, Commo F, Prada N, Poirier-Colame V, Bressac B, Cotteret S, Brugieres L, Farace F, Chaput N, Kroemer G, Valteau-Couanet D, Zitvogel L.

Sci Transl Med. 2015 Apr 15;7(283):283ra55. doi: 10.1126/scitranslmed.aaa2327.

PMID:
25877893
4.

Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.

Al Nakouzi N, Cotteret S, Commo F, Gaudin C, Rajpar S, Dessen P, Vielh P, Fizazi K, Chauchereau A.

Oncotarget. 2014 Feb 15;5(3):667-78.

5.

Sumoylated protein tyrosine phosphatase 1B localizes to the inner nuclear membrane and regulates the tyrosine phosphorylation of emerin.

Yip SC, Cotteret S, Chernoff J.

J Cell Sci. 2012 Jan 15;125(Pt 2):310-6. doi: 10.1242/jcs.086256. Epub 2012 Jan 20.

6.

Regulation of protein tyrosine phosphatase 1B by sumoylation.

Dadke S, Cotteret S, Yip SC, Jaffer ZM, Haj F, Ivanov A, Rauscher F 3rd, Shuai K, Ng T, Neel BG, Chernoff J.

Nat Cell Biol. 2007 Jan;9(1):80-5. Epub 2006 Dec 10.

PMID:
17159996
7.

Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties.

Cotteret S, Chernoff J.

Mol Cell Biol. 2006 Apr;26(8):3215-30.

8.

Bcr-abl translocation can occur during the induction of multidrug resistance and confers apoptosis resistance on myeloid leukemic cell lines.

Belloc F, Cotteret S, Labroille G, Schmit V, Jaloustre C, Dumain P, Durrieu F, Reiffers J, Boisseau MR, Bernard P, Lacombe F.

Cell Death Differ. 1997 Dec;4(8):806-14.

9.

Pak GITs to Aurora-A.

Cotteret S, Chernoff J.

Dev Cell. 2005 Nov;9(5):573-4. Review.

10.

From molecular characteristics to cellular events in apoptosis-resistant HL-60 cells.

Palissot V, Morjani H, Belloc F, Cotteret S, Dufer J, Berchem G.

Int J Oncol. 2005 Mar;26(3):825-34.

PMID:
15703842
11.

p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD.

Cotteret S, Jaffer ZM, Beeser A, Chernoff J.

Mol Cell Biol. 2003 Aug;23(16):5526-39.

12.

The evolutionary history of effectors downstream of Cdc42 and Rac.

Cotteret S, Chernoff J.

Genome Biol. 2002;3(2):REVIEWS0002. Epub 2002 Jan 14. Review.

13.

Caspase cleavage enhances the apoptosis-inducing effects of BAD.

Condorelli F, Salomoni P, Cotteret S, Cesi V, Srinivasula SM, Alnemri ES, Calabretta B.

Mol Cell Biol. 2001 May;21(9):3025-36.

14.

Stable mixed chimerism without relapse after related allogeneic umbilical cord blood transplantation in a child with severe aplastic anemia.

Boiron JM, Cotterêt S, Cony-Makhoul P, Merel P, Micheau M, Perel Y, Belloc F, Bernard P, Reiffers J.

Bone Marrow Transplant. 1998 Oct;22(8):819-21.

15.

Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.

Cotteret S, Belloc F, Boiron JM, Bilhou-Nabera C, Dumain P, Boyer C, Lacombe F, Reiffers J, Bernard P.

Cytometry. 1998 Oct 15;34(5):216-22.

PMID:
9822307

Supplemental Content

Loading ...
Support Center